PureHealth Research continues to expand its approach to full-body wellness with a portfolio of pure health products designed to support interconnected biological systems. Rather than targeting ...

Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the award of an up ...

ARPA-H award supports the development of an oral prodrug using Seaport’s proprietary Glyph™ platform to address dysfunctional ...

Monash University is partnering with the University of Missouri and the University of Pennsylvania to develop first-in-class medicines designed to ...

Monash University is partnering with the University of Missouri and the University of Pennsylvania to develop first-in-class medicines designed to ...

Monash University is partnering with the University of Missouri and the University of Pennsylvania to develop first-in-class medicines designed to reverse poor lymphatic vessel contraction and ...

Seaport Therapeutics and MIPS awarded up to $15 mn from ARPA-H to advance Seaport’s GlyphCele, the first oral therapeutic designed to restore gut lymphatic function: Boston Thur ...

In recognition of Lymphoedema Awareness Month this March, Central Coast healthcare leaders are encouraging patients and ...

Unlike the heart, which pumps blood continuously, the lymphatic system has no central pump. It relies on muscle movement and breathing to circulate lymph fluid through the body. When this flow slows, ...

The project is being led by the Monash Institute of Pharmaceutical Sciences (MIPS) in partnership with long term collaborator, Seaport Therapeutics, and is being backed by up to AUD$21.5M via the ARPA ...

While dry brushing won’t reach the deeper lymph vessels, it can help encourage superficial circulation and support fluid movement when practised consistently. It also builds something arguably just as ...

A team of researchers led by Rice bioengineer Omid Veiseh has been awarded up to $18.2 million in funding from the Advanced Research Projects Agency for Health to develop a first-of-its-kind ...